FDA Approves Drug for AFib and Atrial Flutter in Critical Care Settings
The approval is based on clinical studies that demonstrated the IV treatment enables rapid management of the heart rate with minimal reduction of blood pressure.
Read More
Month: November 2024
Stem Cell-Derived Heart Cells Show Promise for Congenital Heart Defects
Heart muscle cells grown from induced pluripotent stem cells successfully integrated into monkey hearts with pressure overload, a condition often seen in children with congenital heart defects.
Read More
Eko Health Granted CPT Code for AI Heart Disease Detection Platform
Eko Health has been granted a Category III CPT code by the American Medical Association for its Sensora platform, an AI-enabled system for early heart disease detection.
Read More
FDA Greenlights Blood Pressure Monitor with AI AFib Detection
The blood pressure monitor demonstrated high accuracy for AFib detection in a clinical study.
Read More
Polygenic Risk Scores Show Variability in Heart Disease Predictions
New research highlights variability in polygenic risk scores for heart disease, revealing inconsistencies in individual risk predictions that may impact clinical decisions.
Read More